Correlation Between Astellas Pharma and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Astellas Pharma and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astellas Pharma and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Astellas Pharma and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Astellas Pharma and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astellas Pharma with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astellas Pharma and Takeda Pharmaceutical.

Diversification Opportunities for Astellas Pharma and Takeda Pharmaceutical

-0.03

Correlation Coefficient

Astellas Pharma  Takeda Pharmaceutical

Good diversification

The 3 months correlation between Astellas and Takeda is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Astellas Pharma and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Astellas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astellas Pharma are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Astellas Pharma i.e., Astellas Pharma and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Astellas Pharma and Takeda Pharmaceutical

Assuming the 90 days horizon Astellas Pharma is expected to generate 0.52 times more return on investment than Takeda Pharmaceutical. However, Astellas Pharma is 1.93 times less risky than Takeda Pharmaceutical. It trades about 0.06 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about -0.03 per unit of risk. If you would invest  1,009  in Astellas Pharma on May 6, 2025 and sell it today you would earn a total of  48.00  from holding Astellas Pharma or generate 4.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Astellas Pharma  vs.  Takeda Pharmaceutical Co

Astellas Pharma

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Astellas Pharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong primary indicators, Astellas Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Takeda Pharmaceutical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Astellas Pharma and Takeda Pharmaceutical

The main advantage of trading using opposite Astellas Pharma and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astellas Pharma position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Astellas Pharma and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.